Dr. Giovanni Di Leo, from the Research Hospital at Policlinico San Donato in Milan, will detail preliminary results of the Multicenter International Prospective Meta-Analysis of Individual Woman Data (MIPA). As of March 1, 2016, 4,295 patients had been enrolled from 34 imaging centers in 14 countries. So far, 1,926 women (45%) have a complete case report from which researchers can glean multitudes of data.
Of those 1,926 patients, 972 (50.5%) had MRI before surgery. Among the women who have been imaged, MIPA has revealed the following:
- Diffusion-weighted MRI was added to the standard protocol for 816 patients (84%).
- The contrast agent gadobutrol (Gadavist, Bayer HealthCare Pharmaceuticals) was used in 680 cases (70%).
- Cancer was diagnosed during MRI screening of 39 women (4%) and when "problem-solving" in 116 other cases (12%).
Preoperative MRI was ordered by a radiologist in 477 (58%) of 817 cases, while the request came from a surgeon 259 times (32%) and by both a radiologist and surgeon for 50 patients (6%). An oncologist alone or in combination with other physicians requested an MRI in 31 instances (4%).
Di Leo will share more results and additional insights during his talk.
